HomeInsights52 Week High Stocks

Aspira Pathlab & Diagnostics Ltd 52 Week High

Aspira Pathlab & Diagnostics Ltd 52 Week High

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

0.8 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 27, 2024

Image

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRAPATHLAB

YEARHIGH

₹ 79.7

Last updated on: Dec 26, 2024

Key Highlights

  • The 52 Week HIGH of Aspira Pathlab & Diagnostics Ltd is ₹ 79.7 as of 26 Dec 24 .

Company Fundamentals for Aspira Pathlab & Diagnostics Ltd

No data available

Market Price of Aspira Pathlab & Diagnostics Ltd

1M

1Y

3Y

5Y

Monitoring Aspira Pathlab & Diagnostics Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 202460.3
24 Dec 202461.2
23 Dec 202461.2
20 Dec 202462.1
19 Dec 202462.2
18 Dec 202463.46
17 Dec 202464.75
16 Dec 202466.07
13 Dec 202467.41
12 Dec 202468.78

Asset Value vs Market Value of Aspira Pathlab & Diagnostics Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Historical Net Profit of Aspira Pathlab & Diagnostics Ltd

No data available

* All values are in crore

Aspira Pathlab & Diagnostics Ltd News Hub

News

Aspira Pathlab & Diagnostics schedules board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

30 Oct 2024 16:55

News

Aspira Pathlab & Diagnostics AGM scheduled

Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the compan...

Read more

28 Aug 2024 12:02

News

Aspira Pathlab & Diagnostics to announce Quarterly Result

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

05 Aug 2024 14:32

News

Aspira Pathlab & Diagnostics to conduct board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

21 May 2024 12:07

News

Aspira Pathlab & Diagnostics revises board meeting date

Aspira Pathlab & Diagnostics has revised the meeting of the Board of Directors which was s...

Read more

06 Feb 2024 12:39

News

Aspira Pathlab & Diagnostics to conduct board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

02 Feb 2024 15:34

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Aspira Pathlab & Diagnostics Ltd

What is the significance of Aspira Pathlab & Diagnostics Ltd reaching its 52-week high?

Aspira Pathlab & Diagnostics Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Aspira Pathlab & Diagnostics Ltd 52-week high?

Investors monitor Aspira Pathlab & Diagnostics Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Aspira Pathlab & Diagnostics Ltd a good buy when it hits its 52-week high?

Whether Aspira Pathlab & Diagnostics Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Aspira Pathlab & Diagnostics Ltd fundamentals.

What should I consider before investing in Aspira Pathlab & Diagnostics Ltd at its 52-week high?

Before investing in Aspira Pathlab & Diagnostics Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Aspira Pathlab & Diagnostics Ltd stock price continue to rise after reaching its 52-week high?

Aspira Pathlab & Diagnostics Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions